LabBase Plus celebrates pride

薬事担当者

Metagen, Inc.

Job Summary

メタジェンセラピューティクスはマイクロバイオームサイエンスを活用した創薬・医療事業を展開するスタートアップです。ディスバイオーシス(腸内細菌叢の乱れ)を正常化することを「細菌叢再生」と名付け、様々な治療法の開発と普及に取り組んでいます。 FMT(Fecal Microbiota Transplantation)実施基盤や生命科学研究、バイオインフォマティクス研究を活用し、消化器系疾患や免疫系疾患を対象とした複数パイプラインの開発と探索的研究を進めています。また、順天堂大学消化器内科が進めている腸内細菌叢移植療法を用いた臨床研究(潰瘍性大腸炎治療)を社会実装すべく安全で高品質なFMT療法の普及拡大に注力しています。

Company Info

Metagen, Inc. is a research company founded in 2015, originating as a joint venture between Keio University and Tokyo Institute of Technology. Its mission is to make gut environment-based healthcare a new standard by maximizing the potential of the gut environment through integrating scientific knowledge into businesses. The company specializes in providing microbiomics and genomics services, offering comprehensive analysis of the intestinal environment from fecal samples to extract valuable health information. They utilize a unique method called "Metabologenomics®," which integrates data from metagenomics (genetic analysis of gut microbiota) and metabolomics (analysis of gut microbiota-derived metabolites). This approach allows for a comprehensive understanding and evaluation of an individual's gut environment, enabling the development of personalized health plans and preventative measures. Metagen, Inc. aims to achieve a disease-free society by promoting and commercializing "gut design" for stratified healthcare.

Login to see all information about offers.

By registering with LabBase Plus you...

Picture of search page on product

You can select from our vast stock of job offers.

  • Can view all curation offers.
  • Receive notifications of new offers added to curations.
  • Possibly be scouted by corporations.
  • Search for companies with unique technologies.
  • Search for job offers in areas like inorganic chemistry material science.

Registration takes roughly 2 minutes